XML 62 R50.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies - Additional Information (Detail)
 1 Months Ended 6 Months Ended 12 Months Ended
Nov. 05, 2025
USD ($)
Dec. 27, 2022
$ / shares
Dec. 31, 2025
USD ($)
employee
Apr. 30, 2015
USD ($)
Jun. 30, 2026
USD ($)
Dec. 31, 2017
USD ($)
Feb. 14, 2022
ft²
Business Combination [Line Items]              
Operating lease right-of-use assets, net     $ 33,010,000   $ 31,271,000    
Operating lease liabilities         38,711,000    
Commercial milestone commitments         40,800,000    
SRS/Altor Shareholder CVR Arbitration | Pending Litigation              
Business Combination [Line Items]              
Additional merger consideration (in dollar per share) | $ / shares   $ 2.00          
Estimated liability $ 164,200,000            
Settlement interest $ 50,000,000.0            
Dunkirk Facility              
Business Combination [Line Items]              
Number of square foot of facility leased | ft²             409,000
Annual lease payment     500,000        
Option to purchase, amount     1.00        
Operating lease right-of-use assets, net     1,400,000        
Operating lease liabilities     1,400,000        
Commitment to spend, operational expenses, initial lease term     1,520,000,000        
Commitment to spend, operational expenses, renewal lease term     55,000,000.0        
Cumulative capital spending     40,000,000.0        
Annual operating spending     $ 5,000,000.0        
Headcount hiring target | employee     100        
Initial term of lease arrangement     3 years        
Headcount hiring target, exercise option | employee     450        
Term without written consent     5 years        
Altor BioScience Corporation | Contingent Value Rights Payable, Sales Milestone              
Business Combination [Line Items]              
Potential contingent value rights to be earned           $ 304,000,000.0  
Minimum net sales milestone for contingent value rights payable           1,000,000,000.0  
Altor BioScience Corporation | Contingent Value Rights Payable, Sales Milestone | Dr. Soon-Shiong and Related Party              
Business Combination [Line Items]              
Potential contingent value rights to be earned         139,800,000    
Altor BioScience Corporation | Contingent Value Rights Payable, Sales Milestone | Altor Stockholders              
Business Combination [Line Items]              
Potential contingent value rights to be earned         164,200,000    
Altor BioScience Corporation | Contingent Value Rights Obligation, Regulatory Milestone              
Business Combination [Line Items]              
Potential contingent value rights to be earned           $ 304,000,000.0  
Altor BioScience Corporation | Contingent Value Rights Obligation, Regulatory Milestone | Dr. Soon-Shiong and Related Party              
Business Combination [Line Items]              
Potential contingent value rights to be earned         139,800,000    
VivaBioCell              
Business Combination [Line Items]              
Ownership percentage acquired       100.00%      
Business combination, consideration transferred       $ 700,000      
Maximum milestone payment due if certain conditions are met         $ 2,300,000